JOSE LUIS
GORRIZ TERUEL

CONTRATADO/A DOCTOR/A

Foto de JOSE LUIS

Foto de Eli Lilly and Company

Eli Lilly and Company

Indianapolis, EE. UU.

Publikationen in Zusammenarbeit mit Forschern von Eli Lilly and Company (3)

2022

Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations
Diabetes Therapy, Vol. 13, Núm. 3, pp. 389-421

2020

Corrigendum to “Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care” (Primary Care Diabetes (2019) 13(6) (485–494), (S1751991819302190), (10.1016/j.pcd.2019.07.001))
Primary Care Diabetes

2019

Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care
Primary Care Diabetes, Vol. 13, Núm. 6, pp. 485-494